Results 101 to 110 of about 16,465 (200)
Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patients.
International audienceIL-23 is the main inductor in Th17 polarization of naive T cells, inducing IL-17 production. IL-17 has been demonstrated to be elevated in ankylosing spondylitis (AS). The p40 subunit is common to IL-12 and IL-23.
Racadot, Evelyne +2 more
core +1 more source
Purpose: The NHS-IL12 immunocytokine is composed of two IL12 heterodimers fused to the NHS76 antibody. Preclinical studies have shown that this antibody targets IL12 to regions of tumor necrosis by binding histones on free DNA fragments in these areas ...
Montgomery, Agnes S. +14 more
core +1 more source
Introduction: Psoriatic arthritis (PsA) is an inflammatory condition associated with psoriasis (PsO), with variable prevalence ranging from 6% to 42%. Despite the known link between PsO and PsA, reliable biomarkers for predicting PsA onset remain elusive.
R. Rivera-Diaz +5 more
doaj +1 more source
TNFalpha-matured dendritic cells (DCs) pulsed with tumor antigens are being evaluated as cancer vaccines. It has been shown that DCs produce IL12 during a limited time span and subsequently enter a stage of IL12 exhaustion.
Tötterman, Thomas H., +5 more
core +1 more source
Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy
Background Human papillomavirus (HPV)-associated malignancies continue to present a major health concern despite the development of prophylactic vaccines. Standard therapies offer limited benefit to patients with advanced-stage disease.
Jeffrey Schlom +11 more
doaj +1 more source
Th1 and Th2 Immune response in Hymenolepis nana infection
Background & Objective: Although many experimental studies provide convincing evidence, that type II immunity is protective against helminthes, recent data in mice reveal that Th1 are also important in some cestods like Hymenolepis nana.
Abolghasem Ajami +3 more
doaj
Safety and Efficacy of Intratumoral MEDI1191, an IL12 mRNA Lipid Nanoparticle, plus Intravenous Durvalumab in Patients with Advanced Solid Tumors: A First-in-Human Study. [PDF]
Carneiro BA +19 more
europepmc +1 more source
Neutralizing the IL12/IL23 p40 Subunit Prevents Immune Checkpoint Blockade Toxicity without Compromising Antitumor Efficacy. [PDF]
Groeneveldt C +18 more
europepmc +1 more source
Single-Dose TACE-Like Injection of Sustained-Release Panobinostat/IL-12 Polymeric Microparticles is Effective in Preclinical Liver Cancer Models. [PDF]
Yu H +7 more
europepmc +1 more source

